News | Mammography | April 04, 2017

Five-year study employed Kubtec’s Mozart System with TomoSpec technology

digital breast tomosynthesis, DBT, 3-D mammography, breast imaging, re-excision rate, breast surgeries, ECR 2017, Kubtec Mozart System

April 4, 2017 — A study presented at the 2017 European Congress of Radiology (ECR) has concluded that adding digital breast tomosynthesis (DBT) is emerging as promising technology for surgical planning, as it offers a better view of lesion margins than mammography alone. The study results were presented at ECR 2017, March 1-5 in Vienna, Austria, by Alessia Milan, Ph.D., from the University of Turin.

The five-year study of 925 breast cancer patients demonstrated that the use of DBT can reduce re-excision rates by up to 50 percent.

"Margin status is one of the most important predictors for local recurrence following breast cancer surgery, and accurate pre-operative staging helps to plan appropriate surgical treatment and reduce the consequences of re-excision," Milan told meeting attendees. "These consequences can include emotional burden for the patient, a worse cosmetic outcome and higher costs."

The latest tool to use digital tomosynthesis to drive a reduction in positive margins is the Mozart System with TomoSpec Technology from Kubtec. The company said it is the first and only 3-D specimen tomosynthesis system designed specifically for intraoperative use.

Rather than producing a single 2-D planar view of multiple tissue layers, the Mozart System uses 3-D tomosynthesis technology to eliminate tissue interference by digitally removing overlying or underlying tissue in 1mm slices. This means that potential extensions of the cancer, radiating laterally or deep to the lesion, can be seen with greater clarity, helping to decrease the risk of positive margins and optimizing the cosmetic outcome of the procedure.

The Mozart System uses digital tomosynthesis to provide a three-dimensional solution to a three-dimensional problem during the treatment stage of breast cancer.

For more information: www.kubtec.com


Related Content

News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now